Brief: Acrux Signs Agreement With Servacure For Dapsone Gel In Saudi Arabia
31/07/2025 02:34
July 31 (Reuters) - Acrux Ltd ACR.AX: LICENSING PARTNERSHIP IN SAUDI ARABIA FOR DAPSONE 5%, GEL SIGNS AGREEMENT WITH SERVACURE FOR DAPSONE GEL IN SAUDI ARABIA Further company coverage: ACR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acrux
See all newsBrief: Acrux Licenses Lenzetto For Australian Market For A$5.4 Million
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Acrux Says Capital Gains Tax Exemptions Remain In Place For Acrux
Australia's Acrux jumps on placement to fund female testosterone program
Brief: Acrux Raises A$1.6 Mln Via At 0.95 AU Cents Per Share